Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENO1 | P06733 | 2/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | PREP | P48147 | 2/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23884944 | 0.87 | ENO1 (0.37) | ENO1PREPACE2CASP1 | |
| SCHEMBL18048538 | 0.83 | ENO1 (0.47) | ENO1PREPACE2 | |
| SCHEMBL22266122 | 0.82 | ENO1 (0.49) | ENO1PREPACE2 | |
| SCHEMBL23884949 | 0.82 | ALDH1A1 (0.39) | ENO1PREPACE2CHRM4 | |
| SCHEMBL25544654 | 0.81 | MET (0.40) | ENO1PREP | |
| SCHEMBL23884973 | 0.79 | ENO1 (0.43) | ENO1PREPCHRM4 | |
| SCHEMBL23884976 | 0.79 | ENO1 (0.42) | ENO1PREPACE2 | |
| SCHEMBL18048541 | 0.78 | ENO1 (0.39) | ENO1PREPCASP1 | |
| SCHEMBL23884950 | 0.77 | ENO1 (0.45) | ENO1CHRM4 | |
| SCHEMBL25544199 | 0.77 | PIK3CA (0.36) | ENO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167142-A1 | METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167142-A1 | METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES | PHPT1, PPIP5K2, PNP | ENO1 867/4885GFER 3192/4885PREP 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.